The discontinuation of certain testosterone patches is a developing situation impacting patients and the pharmaceutical market.
Why are specific testosterone patches being discontinued?
The discontinuation of some testosterone patch products, such as Androderm, is due to the manufacturer's strategic decision to exit the testosterone replacement therapy market. This decision is not related to the drug's efficacy or safety but rather a business strategy [1].
What are the alternatives to discontinued testosterone patches?
Patients who were using discontinued testosterone patches now have several alternative treatment options. These include other forms of testosterone therapy such as:
* Other testosterone patches: While some are discontinued, other brands may remain available.
* Testosterone injections: These are administered intramuscularly and are a common alternative.
* Testosterone gels and solutions: These are applied topically to the skin.
* Testosterone pellets: These are implanted under the skin and release testosterone over time.
* Oral testosterone: Though less common due to liver concerns historically, some formulations may exist.
The choice of alternative will depend on individual patient needs, physician recommendations, and availability.
When do patents on testosterone therapies expire?
Patent expiry dates for testosterone therapies vary significantly by product and formulation. For instance, the patent for Androderm, a discontinued patch, would have expired, impacting its market exclusivity. Information on specific patent expiries for various testosterone products can be found on resources like DrugPatentWatch.com [2].
What is the impact on the testosterone replacement therapy market?
The discontinuation of significant players like Androderm can lead to shifts in the market. Remaining manufacturers of other testosterone formulations may see increased demand. It also highlights the dynamic nature of pharmaceutical markets, where product availability can change based on manufacturer decisions, patent expirations, and the introduction of new therapies [1][2].
What are patient concerns regarding testosterone patch discontinuation?
Patients are concerned about the availability of suitable alternatives that match the convenience and efficacy of the discontinued patches. They also worry about potential disruptions in their treatment regimen, the need to switch to different delivery methods (e.g., from patch to injection or gel), and the associated costs and insurance coverage changes. Ensuring a smooth transition to an effective and well-tolerated alternative is a primary patient concern [1].
Who manufactures other testosterone replacement therapies?
Several pharmaceutical companies manufacture testosterone replacement therapies in various forms. These include different testosterone patches, injections, gels, and pellets. Specific manufacturers vary by product type and region.
How does testosterone patch therapy work?
Testosterone patches deliver testosterone transdermally, meaning through the skin. The patch is applied to the skin, typically once a day, and releases testosterone gradually over a 24-hour period. This method aims to maintain consistent testosterone levels in the body, mimicking the natural daily rhythm of hormone production [3].
Sources:
1. https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-discontinue-testosterone-replacement-therapy-drug-androderm-2024-01-23/
2. https://drugpatentwatch.com/
3. https://www.ncbi.nlm.nih.gov/books/NBK538105/